@misc{indiciae9ae896c7e5e6,
  title = {Eligibility of real-world patients for aspirin primary prevention trials in cardiovascular disease.},
  author = {Michael Holder and Daniel R Morales and Peter Hanlon and David A McAllister and Bruce Guthrie},
  year = {2026},
  doi = {10.1186/s12916-026-04654-w},
  url = {https://pubmed.ncbi.nlm.nih.gov/41593683/},
  note = {Source identifier: 41593683}
}